Aug 14, 2025 04:05PM
May 8, 2025 04:04PM
May 8, 2025 04:01PM
Jan 21, 2025 09:01AM
Jan 21, 2025 09:00AM
Nov 26, 2024 09:00AM
Oct 29, 2024 09:00AM Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Oct 28, 2024 04:05PM
Sep 16, 2024 09:01AM
Sep 16, 2024 09:00AM
Sep 4, 2024 04:15PM
Aug 14, 2024 04:10PM
Jun 18, 2024 09:01AM
Jun 18, 2024 09:00AM Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
May 14, 2024 09:00AM
Mar 22, 2024 09:02AM
Mar 22, 2024 09:00AM
Jan 23, 2024 04:30PM
Jan 8, 2024 09:01AM
Jan 8, 2024 09:00AM
Dec 11, 2023 09:01AM Shuttle Pharmaceuticals (SHPH) Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma
Dec 11, 2023 09:00AM
Nov 14, 2023 09:00AM
Sep 25, 2023 09:01AM
Sep 25, 2023 09:00AM
Aug 15, 2023 09:00AM
Aug 3, 2023 09:00AM
May 26, 2023 09:00AM Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update
Mar 15, 2023 09:05AM
Mar 15, 2023 09:00AM
Mar 9, 2023 09:00AM
Feb 23, 2023 09:01AM
Feb 23, 2023 09:00AM
Nov 15, 2022 09:00AM
Nov 3, 2022 09:00AM Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study
Sep 20, 2022 09:02AM
Sep 20, 2022 09:00AM

323,630 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All